WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

A REVIEW ON CARDIOVASCULAR DISEASE EFFECT IN CORONA PATIENTS

*Md. Zulphakar Ali, Pankaj Chasta, Dr. Gaurav Kumar Sharma and Dr. Kaushal Kishore Chandrul

ABSTRACT

Cardiovascular disease (CVD) is a hearts cardiovascular disease includes coronary artery such as angina heart attack cardiomyopathy co morbidities, hypertensive disease. Cardiovascular disease effect in covid-19 many patients with corona virus disease have underlying cardiovascular disease or develop acute cardiac injury during the large of the illness adequate underlying of the interplay between covid-19 (CV) disease is required for optimum management of these patients, cardiovascular disease is responsible of more number of death world-wide, the muscle and vessels of heart and blood transporting roods become vulnerable patients in most of the (CVD) the role of hypertension and cholesterols of different density triglycerides in induction and progression of cardiovascular disease, Besides this the patent biomarkers such as mono cytosine, fibrinogen, D-dimmer and thrombin/ anti thrombin interleukin, severe acute respiratory syndrome-corona virus (SARS-CoV-2) can manifest acutely and persist into convalescence and possibly beyond. Coronavirus disease 2019 (COVID-19), caused by a strain of corona virus known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of billions of individuals. Clinical studies have also reported an association between COVID-19 and cardiovascular disease. Pre-existing cardiovascular disease seems to be linked with worse outcomes and increased risk of death in patients with COVID-19, whereas COVID-19 itself can also induce myocardial injury, arrhythmia, acute coronary syndrome and venous thromboembolism. Potential drug–disease interactions affecting patients with COVID-19 and co morbid cardiovascular diseases are also becoming a serious concern.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More